Plus Therapeutics Announces Positive Interim Data from ReSPECT™ Phase 1 Clinical Trial in Recurrent Glioblastoma Nasdaq:PSTV

Media coverage

• Title	Plus Therapeutics Announces Positive Interim Data from ReSPECT™ Phase 1 Clinical Trial in Recurrent Glioblastoma Nasdaq:PSTV
  Media name/outlet	MENAFN -Press Releases (English)
  Country	Jordan
  Date	11/19/20
  Persons	Andrew Brenner

• Title	Plus Therapeutics Announces Positive Interim Data from ReSPECT™ Phase 1 Clinical Trial in Recurrent Glioblastoma Nasdaq:PSTV
  Media name/outlet	Global English (Middle East and North Africa Financial Network)
  Country	Jordan
  Date	11/19/20
  Persons	Andrew Brenner